以水替代人工甜味饮料对2型糖尿病患者血糖和体重指标的影响:SODAS随机试验
SODAS试验在两家学术健康中心开展,为随机、双臂、平行试验,纳入181例定期消费商业人工甜味饮料(ASB)且HbA1c 6.5-8.5%的2型糖尿病成人,随机分为继续饮用ASB(对照)或改饮瓶装/罐装水24周。结果179例完成数据,水组HbA1c变化均值较ASB组高0.29%(SE 0.12;P=0.013),次要临床指标无显著影响。结论:对于HbA1c<8.5%且定期消费ASB的2型糖尿病患者,用水平替ASB 24周无证据改善血糖相关临床指标。
要点
- 水替代ASB组HbA1c变化比ASB组高0.29%(P=0.013),未显示血糖获益。
- 次要指标(果糖胺、空腹血糖胰岛素、体重、CGM)无显著差异但方向一致。
- 针对HbA1c<8.5%且习惯饮用ASB的2型糖尿病患者,不建议以水替代作为改善血糖的策略。
核心结论
- 对于HbA1c<8.5%且定期消费ASB的2型糖尿病患者,用水平替ASB 24周无证据改善血糖相关临床指标。
研究设计与样本
- SODAS是在两家学术健康中心开展的随机、双臂、平行试验,含2周导入期和24周干预期。
- 纳入181例年龄≥35岁、HbA1c 6.5-8.5%且定期消费商业ASB的2型糖尿病成人。
- 随机分为每日24 oz商业ASB(对照)或等量瓶装/罐装水替代ASB,共24周。
- 179例提供24周完整数据;结局在基线、12周和24周收集。
主要发现
- 从基线到24周,水组HbA1c变化均值较ASB组高0.29%(SE 0.12;P=0.013)。
- 次要临床指标(果糖胺、空腹血糖和胰岛素、体重、连续血糖监测指标)无显著影响,但数据方向与主要结果一致。
临床怎么用
- 对于HbA1c<8.5%且习惯饮用ASB的2型糖尿病患者,不应将水替代ASB作为改善血糖控制的手段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test the effect of substituting plain water (the ideal standard) for habitual artificial sweetened beverage (ASB) intake by people with type 2 diabetes (T2D) on primary measures of diabetes control. RESEARCH DESIGN AND METHODS: The Study of Drinks with Artificial Sweeteners in People with T2D (SODAS) was conducted at two academic health centers and was a randomized, two-arm, parallel trial with a 2-week run-in period and a 24-week active intervention period. Adults with T2D (n = 181; HbA1c 6.5-8.5%; aged ≥35 years) who regularly consumed commercial ASBs were randomized to receive and consume 24 oz daily for 24 weeks of either 1) a commercial ASB of choice (control) or 2) an unflavored, sparkling or still, bottled or canned water of choice in place of ASBs. The outcomes measures were collected at baseline, 12, and 24 weeks and included the primary measure (HbA1c) and related secondary measures (fructosamine, fasting glucose and insulin, body weight, and continuous glucose monitor metrics). RESULTS: A total of 179 participants provided complete data over 24 weeks. From baseline to 24 weeks, the mean difference in change of HbA1c was 0.29% (SE 0.12; P = 0.013) higher in the water arm compared with the ASB arm. There were no significant effects on secondary clinical measures, but data were directionally consistent with the primary results. CONCLUSIONS: For people with T2D and HbA1c <8.5% who regularly consume ASBs, this trial provided no evidence that substituting water would improve glycemic-related clinical care measures over 24 weeks.
引用
- Odegaard AO, Chang J, Jiang L, et al. The Effect of Substituting Water for Artificially Sweetened Beverages on Glycemic and Weight Measures in People With Type 2 Diabetes: The Study of Drinks With Artificial Sweeteners (SODAS), a Randomized Trial. Diabetes Care. 2026. PMID: 41369640. doi:10.2337/dc25-1516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。